✦ LIBER ✦

Erythropoietin in the UK: a setback for gene patents?

✍ Scribed by Crespi, R Stephen

Book ID: 109902027
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 74 KB
Volume: 23
Category: Article
ISSN: 1087-0156
DOI: 10.1038/nbt0305-367

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

UK clinical geneticists ask for ban on t

UK clinical geneticists ask for ban on the patenting of human genes

✍ Dickson, David 📂 Article 📅 1993 🏛 Nature Publishing Group 🌐 English ⚖ 142 KB

Opinion: Is there a future for 'speculat

Opinion: Is there a future for 'speculative' gene patents in Europe?

✍ Crease, Devanand J.; Schlich, George W. 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 210 KB

Building a fast–track patent portfolio i

Building a fast–track patent portfolio in the UK and Europe

✍ Baldock, Claire; Murphy, Colm 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 983 KB

A shadow falls over gene patents in the

A shadow falls over gene patents in the United States and Europe

✍ Morgan, Gareth; Haile, Lisa A. 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 159 KB

A nail in the coffin for DNA sequence pa

A nail in the coffin for DNA sequence patents?

✍ Yamanaka, Miles 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

In vivo expansion of gene-modified hemat

In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch

✍ Takeyuki Nagashima; Yasuji Ueda; Yutaka Hanazono; Akihiro Kume; Hiroaki Shibata; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 314 KB 👁 1 views

## Abstract ## Background __In vivo__ expansion of gene‐modified cells would be a promising approach in the field of hematopoietic stem cell gene therapy. To this end, we previously developed a selective amplifier gene (SAG), a chimeric gene encoding the granulocyte colony‐stimulating factor (G‐CS